Vertex (VRTX), CRISPR to Seek FDA Nod for Hemoglobinopathy TherapyZacks Investment Research • 09/28/22
Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022Business Wire • 09/27/22
4 Stocks To Watch In Today's Stock Market: Hostess, J.M. Smucker, Toro, VertexInvestors Business Daily • 09/26/22
Vertex Pharmaceuticals: Clinical Data Supports A Favorable Long-Term Growth OutlookSeeking Alpha • 09/19/22